BEIJING, Sept 18, 2008 (AFP) - China should compensate thousands of people infected with the HIV virus through government-backed blood trading and be given access to the latest anti-AIDS drugs, a top UN official said Thursday.
Peter Piot, director of UNAIDS, said he would raise the issue with China's top leaders and urge compensation for who contracted HIV after selling blood in the central province of Henan.
"People are still basically waiting for compensation," Piot said of the illegal and unsanitary blood trade that rocked the province in the late 1990s and early this decade.
"It is incredibly tragic... the issue of compensation, in the courts, is something that has not been resolved. I will definitely raise the issue (with China's leaders)."
Piot will meet on Friday with Vice Premier Li Keqiang, who once headed Henan province and is currently in charge of China's HIV/AIDS programme.
China has about 700,000 HIV/AIDS carriers, with an estimated 50,000 people infected in 2007, according to UNAIDS.
Up to 40,000 of China's overall number of HIV/AIDS patients live in Henan, one of the nation's hardest hit provinces. Many were infected in unsanitary blood collection drives that had been approved by local governments.
Although the government has set out guidelines to provide the Henan patients with the latest in AIDS drugs, the medication was not finding its way into the region, Piot said.
"People are still dying because they cannot have access to what we call second and third-line drugs," Piot said.
"In AIDS treatment, people are treated with first-line drugs, but gradually the virus develops resistance to these drugs so they need what we call second line, these are more expensive drugs, newer drugs."
080918
AF080905
Copyright ©AFP 2008. All Rights Reserved. AFP articles contained on the AEGiS web site may not be reproduced, distributed, transmitted, displayed, published or broadcast without AFP's prior written permission. You may make one copy of each article for your personal, non-commercial use only; more copies would require AFP's prior written permission obtained from the owners of any trademarks or copyrighted materials whose marks and materials are included in AFP photos or materials. Therefore you will be solely responsible for obtaining any and all necessary releases from whatever individuals and/or entities necessary for any uses of AFP stories, photos or graphics. http://www.afp.com/
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.